Tactogen

Developing new MDMA-like medicines for effective prescription mental wellness.

https://wefunder.com/tactogen

Total raised on Wefunder: 92942

Total investors: 158

Quick facts

  • Tactogen is a public benefit corporation making entactogen (MDMA-like) molecules.
  • CEO leverages 30+ years of experience in psychedelic preclinical and clinical research.
  • Many lead compounds ready for safety and toxicity studies. $2-4 million will complete that process.
  • Raised $6.3 million over 2.5 years from well known investors.
  • Significant potential to improve mental health treatment for millions of people.

Team profiles

Featured investor profiles

Tactogen

Developing new MDMA-like medicines for effective prescription mental wellness

What Investors Say

Adjunct Professor of Bioengineering and Experimental Sciences at UCSF
LEAD INVESTOR
Invested $5,000 this round
I’m investing in Tactogen because they have made great progress in designing and developing novel entactogens, and are simultaneously applying a novel business/funding structure. Tactogen has a deep appreciation for the role of community and connection in healing and wellness. If successful, Tactogen could support healing in many people and improve health equity writ large. I am excited about this journey, and hope that other companies in our young sector will take note.
What People Say